Inventor
WU LIFANG
CN13 patents
⚠️ This page may combine multiple inventors who share the name “WU LIFANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV BEIJING TECHNOLOGY
5 patentsUS11225018B2Jan 18, 2022
3D printing method and device with multi-axis mechanical system and visual surveillance
UNIV BEIJING TECHNOLOGY2 citations66
US10759110B2Sep 1, 2020
Light homogenization method for multi-source large-scale surface exposure 3D printing
UNIV BEIJING TECHNOLOGY1 citations56
US11745431B1Sep 5, 2023
Rapid DLP 3D printing control parameter optimization method combining continuous and layered molding
UNIV BEIJING TECHNOLOGY1 citations53
US11353845B2Jun 7, 2022
Model-adaptive multi-source large-scale mask projection 3D printing system
UNIV BEIJING TECHNOLOGY0 citations43
US11360464B2Jun 14, 2022
High intensity multi direction FDM 3D printing method for stereo vision monitoring
UNIV BEIJING TECHNOLOGY0 citations41
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
4 patentsUS9962388B2May 8, 2018
Pyrrolopyrimidine compounds used as TLR7 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD14 citations83
US10555949B2Feb 11, 2020
Pyrrolopyrimidine compounds used as TLR7 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2 citations72
US10676478B2Jun 9, 2020
7-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations51
US11572372B2Feb 7, 2023
Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
GENFLEET THERAPEUTICS SHANGHAI INC
2 patentsUS10548883B2Feb 4, 2020
Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor
GENFLEET THERAPEUTICS SHANGHAI INC1 citations60
US11236112B2Feb 1, 2022
Crystal form and salt form of TGF-βRI inhibitor and preparation method therefor
GENFLEET THERAPEUTICS SHANGHAI INC0 citations59